Clinical Trials on Triple Negative Breast Neoplasms in New Zealand
Total 2086 results
-
Joseph SparanoRecruitingBreast Neoplasms | Breast Diseases | Metastatic Triple Negative Breast CancerUnited States
-
Mridula George, MDRecruitingOCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerTriple Negative Breast Cancer (TNBC)United States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Cedars-Sinai Medical CenterCompletedBreast Cancer | Metastatic Triple NegativeUnited States
-
Yale UniversityIovance Biotherapeutics, Inc.CompletedMetastatic Triple Negative Breast CancerUnited States
-
SynCore Biotechnology Co., Ltd.Suspended
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Novartis PharmaceuticalsTerminatedTriple Negative Breast Cancer (TNBC)Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
-
Calithera Biosciences, IncCompletedTriple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Roswell Park Cancer InstituteAIM ImmunoTech Inc.CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple -Negative Breast Cancer | Anatomic Stage IV Breast Cancer AJCCUnited States
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast Carcinoma | Refractory Triple-Negative Breast CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaRecruitingMetastatic Triple Negative Breast CancerAustralia
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
Gilead SciencesActive, not recruitingTriple-Negative Breast CancerUnited States, United Kingdom, Australia, Hong Kong, Korea, Republic of, Taiwan
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Breast Cancer Stage IV | Locally Advanced Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Triple-Negative Breast CarcinomaUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerIsrael, United States, Australia, Korea, Republic of, Belgium, Argentina, Denmark, Finland, Italy, Portugal, Spain, Taiwan, Thailand, Japan, United Kingdom, Brazil, Canada, Colombia, Mexico, France, Costa Rica, Switzerland, Czechia, P... and more
-
Yale UniversityCompletedBreast NeoplasmsUnited States
-
Eisai Inc.Merck Sharp & Dohme LLCCompleted
-
amy tierstenNovartisActive, not recruiting
-
Columbia UniversityWyeth is now a wholly owned subsidiary of Pfizer; Genentech, Inc.CompletedTriple Negative Breast CancerUnited States
-
Columbia UniversityRecruitingTriple Negative Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Mridula George, MDNational Cancer Institute (NCI); Incyte Corporation; Oncolytics BiotechRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Triple-negative Breast Cancer | Metastatic Triple-Negative Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
NYU Langone HealthNational Institutes of Health (NIH)TerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
Hackensack Meridian HealthBreast Cancer Research FoundationRecruitingTriple Negative Breast CancerUnited States
-
Icahn School of Medicine at Mount SinaiChampions OncologyCompletedTriple Negative Breast CancerUnited States
-
Columbia UniversityAstellas Pharma Inc; Susan G. Komen Breast Cancer FoundationCompleted
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruiting
-
Roswell Park Cancer InstituteNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
Merrimack PharmaceuticalsSanofiCompletedER Positive, Her2 Negative Breast Cancer Patients | Triple Negative Breast Cancer PatientsUnited States
-
Kari WisinskiNovartis; University of Wisconsin, Madison; Big Ten Cancer Research ConsortiumRecruiting
-
Memorial Sloan Kettering Cancer CenterClovis Oncology, Inc.Active, not recruiting
-
Eileen ConnollyMerck Sharp & Dohme LLCRecruitingTriple Negative Breast CancerUnited States
-
PharmAbcineActive, not recruitingTriple Negative Breast CancerAustralia
-
Memorial Sloan Kettering Cancer CenterCedars-Sinai Medical CenterCompletedLocally Recurrent/Metastatic Triple Negative Breast CancerUnited States
-
Hoffmann-La RocheCompletedTriple-negative Breast CancerUnited States, Korea, Republic of, Canada, United Kingdom, Belgium, Brazil, Germany, Taiwan, Australia, Japan, Spain, Poland, Italy
-
Alison StopeckRecruitingBreast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | TNBC, Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Neoadjuvant ChemotherapyUnited States
-
Georgetown UniversityBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
Marker Therapeutics, Inc.CompletedBreast CancerUnited States
-
Massachusetts General HospitalAstraZeneca; OncoPep, Inc.Active, not recruitingBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerFrance, Canada, Israel, Italy, Argentina, Brazil, China, Croatia, Germany, Greece, Slovakia, Turkey, Saudi Arabia, Japan, India, Spain, United States, Czechia, Romania, United Kingdom, Morocco, South Africa, Vietnam, Russian Federation
-
St Vincent's Hospital, SydneyRecruitingTriple Negative Breast CancerAustralia
-
PfizerAstellas Pharma Inc; Medivation, Inc.Withdrawn
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Rexahn Pharmaceuticals, Inc.TerminatedSolid Tumor | Triple Negative Breast CancerUnited States
-
Celldex TherapeuticsCompletedMetastatic gpNMB Over-expressing Triple Negative Breast CancerUnited States, France, Spain, Italy, Canada, Germany, Australia, Belgium, United Kingdom
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States